   |
|
|
 |
| Event - Nycomed and Forest approaching Daxas approval decisions |
|
|
| February 08, 2010 |
| Event - Milestones from Exalgo approval will boost CombinatoRx's fortunes |
|
|
| February 08, 2010 |
| TopoTarget delivers deal and delights investors |
|
It might not have been the name that everyone was expecting, but the effect on TopoTarget’s shares after it announced it was out-licensing its most advanced product would have been more than welcome ...
|
| February 08, 2010 |
| Event - EU judgement could turn up heat in Basilea-J&J spat |
|
|
| February 05, 2010 |
| EP Vantage Interview - Regado seeking solution to clotting conundrum |
|
Changes are certainly afoot in the anti-thrombotic landscape, what with the approaching loss of patent protection for Lovenox and Plavix, which generated combined sales of $14bn last year, and the ...
|
| February 05, 2010 |
| Alkermes aiming to shake up CNS market with new technology |
|
|
| February 05, 2010 |
|
|
|
|
|
|
<PARAMS currencyId="0"><PARAM linkKind="0" compId="co_1" all="true" /></PARAMS>
|
|
|
|
|
|
 |
|
Retrieving Data
|
|